• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

封面文章:疾病诱导的纳米颗粒生物冠形成差异及其毒理学后果

From the Cover: Disease-Induced Disparities in Formation of the Nanoparticle-Biocorona and the Toxicological Consequences.

作者信息

Shannahan Jonathan H, Fritz Kristofer S, Raghavendra Achyut J, Podila Ramakrishna, Persaud Indushekar, Brown Jared M

机构信息

*Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045;

Department of Physics and Astronomy, Clemson University, Clemson, South Carolina, 29634; Clemson Nanomaterials Center and COMSET, Clemson University, Anderson, South Carolina, 29625.

出版信息

Toxicol Sci. 2016 Aug;152(2):406-16. doi: 10.1093/toxsci/kfw097. Epub 2016 Jun 2.

DOI:10.1093/toxsci/kfw097
PMID:27255384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4960912/
Abstract

Nanoparticle (NP) association with macromolecules in a physiological environment forms a biocorona (BC), which alters NP distribution, activity, and toxicity. While BC formation is dependent on NP physicochemical properties, little information exists on the influence of the physiological environment. Obese individuals and those with cardiovascular disease exist with altered serum chemistry, which is expected to influence BC formation and NP toxicity. We hypothesize that a BC formed on NPs following incubation in hyperlipidemic serum will result in altered NP-BC protein content, cellular association, and toxicity compared to normal serum conditions. We utilized Fe3O4 NPs, which are being developed as MRI contrast and tumor targeting agents to test our hypothesis. We used rat aortic endothelial cells (RAECs) within a dynamic flow in vitro exposure system to more accurately depict the in vivo environment. A BC was formed on 20nm PVP-suspended Fe3O4 NPs following incubation in water, 10% normal or hyperlipidemic rat serum. Addition of BCs resulted in increased hydrodynamic size and decreased surface charge. More cholesterol associated with Fe3O4 NPs after incubation in hyperlipidemic as compared with normal serum. Using quantitative proteomics, we identified unique differences in BC protein components between the 2 serum types. Under flow conditions, formation of a BC from both serum types reduced RAECs association of Fe3O4 NPs. Addition of BCs was found to exacerbate RAECs inflammatory gene responses to Fe3O4 NPs (Fe3O4-hyperlipidemic > Fe3O4-normal > Fe3O4) including increased expression of IL-6, TNF-α, Cxcl-2, VCAM-1, and ICAM-1. Overall, these findings demonstrate that disease-induced variations in physiological environments have a significant impact NP-BC formation, cellular association, and cell response.

摘要

在生理环境中,纳米颗粒(NP)与大分子结合形成生物冠(BC),这会改变NP的分布、活性和毒性。虽然BC的形成取决于NP的物理化学性质,但关于生理环境影响的信息却很少。肥胖个体和患有心血管疾病的人血清化学成分发生改变,预计这会影响BC的形成和NP毒性。我们假设,与正常血清条件相比,在高脂血症血清中孵育后在NP上形成的BC将导致NP - BC蛋白质含量、细胞结合及毒性发生改变。我们利用正被开发用作磁共振成像造影剂和肿瘤靶向剂的Fe3O4纳米颗粒来验证我们的假设。我们在动态流动体外暴露系统中使用大鼠主动脉内皮细胞(RAEC),以更准确地描绘体内环境。在水中、10%正常或高脂血症大鼠血清中孵育后,20nm聚乙烯吡咯烷酮(PVP)悬浮的Fe3O4纳米颗粒上形成了BC。添加BC会导致流体动力学尺寸增加和表面电荷减少。与正常血清相比,在高脂血症血清中孵育后,更多胆固醇与Fe3O4纳米颗粒结合。使用定量蛋白质组学,我们确定了两种血清类型之间BC蛋白质成分的独特差异。在流动条件下,两种血清类型形成的BC均降低了RAEC对Fe3O4纳米颗粒的结合。发现添加BC会加剧RAEC对Fe3O4纳米颗粒的炎症基因反应(Fe3O4 - 高脂血症>Fe3O4 - 正常>Fe3O4),包括白细胞介素 - 6(IL - 6)、肿瘤坏死因子 - α(TNF - α)、趋化因子配体2(Cxcl - 2)、血管细胞黏附分子 - 1(VCAM - 1)和细胞间黏附分子 - 1(ICAM - 1)表达增加。总体而言,这些发现表明,疾病引起的生理环境变化对NP - BC的形成、细胞结合及细胞反应有重大影响。

相似文献

1
From the Cover: Disease-Induced Disparities in Formation of the Nanoparticle-Biocorona and the Toxicological Consequences.封面文章:疾病诱导的纳米颗粒生物冠形成差异及其毒理学后果
Toxicol Sci. 2016 Aug;152(2):406-16. doi: 10.1093/toxsci/kfw097. Epub 2016 Jun 2.
2
Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.关于疾病状态下纳米颗粒-生物被膜的体外研究的实验挑战。
Toxicol In Vitro. 2018 Sep;51:40-49. doi: 10.1016/j.tiv.2018.05.003. Epub 2018 May 5.
3
Altered formation of the iron oxide nanoparticle-biocorona due to individual variability and exercise.由于个体差异和运动导致氧化铁纳米颗粒-生物被膜的形成发生改变。
Environ Toxicol Pharmacol. 2018 Sep;62:215-226. doi: 10.1016/j.etap.2018.07.014. Epub 2018 Jul 29.
4
Modulation of Pulmonary Toxicity in Metabolic Syndrome Due to Variations in Iron Oxide Nanoparticle-Biocorona Composition.由于氧化铁纳米颗粒-生物冠层组成的变化对代谢综合征中肺毒性的调节作用。
Nanomaterials (Basel). 2022 Jun 11;12(12):2022. doi: 10.3390/nano12122022.
5
An Integrative Proteomic/Lipidomic Analysis of the Gold Nanoparticle Biocorona in Healthy and Obese Conditions.健康和肥胖条件下金纳米颗粒生物冠的蛋白质组学/脂质组学综合分析
Appl In Vitro Toxicol. 2019 Sep 1;5(3):150-166. doi: 10.1089/aivt.2019.0005. Epub 2019 Sep 17.
6
Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state.与单壁碳纳米管结构缺陷和高脂血症疾病状态相关的生物被膜形成变化。
Sci Rep. 2017 Aug 16;7(1):8382. doi: 10.1038/s41598-017-08896-w.
7
Size-dependent tissue-specific biological effects of core-shell structured FeO@SiO-NH nanoparticles.核壳结构 FeO@SiO-NH 纳米粒子的尺寸依赖性组织特异性生物效应。
J Nanobiotechnology. 2019 Dec 23;17(1):124. doi: 10.1186/s12951-019-0561-4.
8
Biocorona formation contributes to silver nanoparticle induced endoplasmic reticulum stress.生物 corona 形成导致银纳米颗粒诱导的内质网应激。
Ecotoxicol Environ Saf. 2019 Apr 15;170:77-86. doi: 10.1016/j.ecoenv.2018.11.107. Epub 2018 Dec 4.
9
Effects of starch-coating of magnetite nanoparticles on cellular uptake, toxicity and gene expression profiles in adult zebrafish.磁性纳米粒子淀粉包被对成年斑马鱼细胞摄取、毒性和基因表达谱的影响。
Sci Total Environ. 2018 May 1;622-623:930-941. doi: 10.1016/j.scitotenv.2017.12.018. Epub 2017 Dec 13.
10
Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles.氧化铁纳米颗粒的涂层依赖性细胞毒性和基因毒性诱导
Nanotoxicology. 2015 May;9 Suppl 1:44-56. doi: 10.3109/17435390.2013.847505. Epub 2013 Nov 14.

引用本文的文献

1
Protective Effect of Silver Nanoparticles Against Cytosine Arabinoside Genotoxicity: An In Vivo Micronucleus Assay.银纳米颗粒对阿糖胞苷遗传毒性的保护作用:一项体内微核试验
Int J Environ Res Public Health. 2024 Dec 18;21(12):1689. doi: 10.3390/ijerph21121689.
2
Quantum Dot Imaging Agents: Haematopoietic Cell Interactions and Biocompatibility.量子点成像剂:造血细胞相互作用和生物相容性。
Cells. 2024 Feb 18;13(4):354. doi: 10.3390/cells13040354.
3
Mechanical Stimulation: A Crucial Element of Organ-on-Chip Models.机械刺激:芯片上器官模型的关键要素。
Front Bioeng Biotechnol. 2020 Dec 10;8:602646. doi: 10.3389/fbioe.2020.602646. eCollection 2020.
4
An Integrative Proteomic/Lipidomic Analysis of the Gold Nanoparticle Biocorona in Healthy and Obese Conditions.健康和肥胖条件下金纳米颗粒生物冠的蛋白质组学/脂质组学综合分析
Appl In Vitro Toxicol. 2019 Sep 1;5(3):150-166. doi: 10.1089/aivt.2019.0005. Epub 2019 Sep 17.
5
Biocorona-induced modifications in engineered nanomaterial-cellular interactions impacting biomedical applications.生物 corona 诱导的工程纳米材料-细胞相互作用的修饰,影响生物医学应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 May;12(3):e1608. doi: 10.1002/wnan.1608. Epub 2019 Dec 1.
6
Antioxidant Potential of Artemisia capillaris, Portulaca oleracea, and Prunella vulgaris Extracts for Biofabrication of Gold Nanoparticles and Cytotoxicity Assessment.茵陈蒿、马齿苋和夏枯草提取物用于生物合成金纳米颗粒的抗氧化潜力及细胞毒性评估
Nanoscale Res Lett. 2018 Oct 30;13(1):348. doi: 10.1186/s11671-018-2751-7.
7
Formation of a protein corona influences the biological identity of nanomaterials.蛋白质冠层的形成会影响纳米材料的生物学特性。
Rep Pract Oncol Radiother. 2018 Jul-Aug;23(4):300-308. doi: 10.1016/j.rpor.2018.05.005. Epub 2018 May 28.
8
Altered formation of the iron oxide nanoparticle-biocorona due to individual variability and exercise.由于个体差异和运动导致氧化铁纳米颗粒-生物被膜的形成发生改变。
Environ Toxicol Pharmacol. 2018 Sep;62:215-226. doi: 10.1016/j.etap.2018.07.014. Epub 2018 Jul 29.
9
Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.关于疾病状态下纳米颗粒-生物被膜的体外研究的实验挑战。
Toxicol In Vitro. 2018 Sep;51:40-49. doi: 10.1016/j.tiv.2018.05.003. Epub 2018 May 5.
10
The biocorona: a challenge for the biomedical application of nanoparticles.生物冠层:纳米颗粒生物医学应用面临的一项挑战。
Nanotechnol Rev. 2017 Aug;6(4):345-353. doi: 10.1515/ntrev-2016-0098. Epub 2017 Jan 20.

本文引用的文献

1
Impact of Silver and Iron Nanoparticle Exposure on Cholesterol Uptake by Macrophages.银和铁纳米颗粒暴露对巨噬细胞摄取胆固醇的影响。
J Nanomater. 2015;2015. doi: 10.1155/2015/127235.
2
A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO.一种用于近红外响应性一氧化氮释放的新型自组装夹心纳米药物。
Nanoscale. 2015 Dec 21;7(47):20055-62. doi: 10.1039/c5nr06630a. Epub 2015 Nov 16.
3
A hyperspectral and toxicological analysis of protein corona impact on silver nanoparticle properties, intracellular modifications, and macrophage activation.蛋白质冠层对银纳米颗粒性质、细胞内修饰和巨噬细胞激活影响的高光谱和毒理学分析。
Int J Nanomedicine. 2015 Oct 13;10:6509-21. doi: 10.2147/IJN.S92570. eCollection 2015.
4
Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.超顺磁性氧化铁纳米蠕虫表面涂层在补体调理作用和白细胞摄取中的调节作用
ACS Nano. 2015 Nov 24;9(11):10758-68. doi: 10.1021/acsnano.5b05061. Epub 2015 Oct 21.
5
The influence of flow, shear stress and adhesion molecule targeting on gold nanoparticle uptake in human endothelial cells.流动、剪切应力和黏附分子靶向对人内皮细胞摄取金纳米颗粒的影响。
Nanoscale. 2015 Jul 14;7(26):11409-19. doi: 10.1039/c5nr01467k.
6
Implications of scavenger receptors in the safe development of nanotherapeutics.清道夫受体在纳米治疗药物安全研发中的意义。
Receptors Clin Investig. 2015;2(3):e811. doi: 10.14800/rci.811.
7
The effect of shear flow on nanoparticle agglomeration and deposition in in vitro dynamic flow models.剪切流对体外动态流动模型中纳米颗粒团聚和沉积的影响。
Nanotoxicology. 2016;10(1):74-83. doi: 10.3109/17435390.2015.1018978. Epub 2015 May 11.
8
Multiscale Imaging of Nanoparticle Drug Delivery.纳米颗粒药物递送的多尺度成像
Curr Drug Targets. 2015;16(6):560-70. doi: 10.2174/1389450116666150202163022.
9
Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.银纳米颗粒的物理化学性质对肥大细胞活化和脱颗粒的影响。
Toxicol In Vitro. 2015 Feb;29(1):195-203. doi: 10.1016/j.tiv.2014.10.008.
10
Progress in the delivery of nanoparticle constructs: towards clinical translation.纳米颗粒构建体递送的进展:迈向临床转化。
Curr Opin Pharmacol. 2014 Oct;18:120-8. doi: 10.1016/j.coph.2014.09.019. Epub 2014 Oct 15.